NOVEL AGENTS AND PARADIGMS IN DEVELOPMENT IN HNSCC

被引:0
|
作者
Jimeno, A. [1 ]
机构
[1] Univ Colorado, Sch Med, Aurora, CO USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:43 / 43
页数:1
相关论文
共 50 条
  • [1] Acute Myeloid Leukemia: Changing Treatment Paradigms and Novel Agents in Development
    Konig, Heiko
    Zeidner, Joshua F.
    CURRENT CANCER DRUG TARGETS, 2020, 20 (07) : 471 - 472
  • [2] Pharmacotherapy for obesity: novel agents and paradigms
    Manning, Sean
    Pucci, Andrea
    Finer, Nicholas
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2014, 5 (03) : 135 - 148
  • [3] Novel Peptide NIRF Optical Surgical Navigation Agents for HNSCC
    Ding, Haiming
    Kothandaraman, Shankaran
    Gong, Li
    Wright, Chadwick L.
    Pan, Quintin
    Teknos, Theodore
    Tweedle, Michael F.
    MOLECULES, 2019, 24 (17):
  • [4] Novel oral anticoagulation agents: New drugs create new paradigms
    Levy, Jerrold H.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 148 (05): : 1802 - 1803
  • [5] Evolving Paradigms in the Management of Multiple Myeloma: Novel Agents and Targeted Therapies
    Jeremy T. Larsen
    Shaji Kumar
    Rare Cancers and Therapy, 2015, 3 (1-2): : 47 - 68
  • [6] Immunotherapy with checkpoint inhibitors for lung cancer: novel agents, biomarkers and paradigms
    Monteiro, Ines-de-Paula
    Califano, Raffaele
    Mountzios, Giannis
    de Mello, Ramon Andrade
    FUTURE ONCOLOGY, 2016, 12 (04) : 551 - 564
  • [7] DEVELOPMENT OF NOVEL THROMBOLYTIC AGENTS
    COLLEN, D
    DEBONO, DP
    LIJNEN, HR
    PANNEKOEK, H
    JOURNAL OF INTERNAL MEDICINE, 1994, 236 (04) : 433 - 437
  • [8] New molecules/promising new agents in HNSCC
    Siu, Lillian L.
    ORAL ONCOLOGY, 2011, 47 : S12 - S12
  • [10] Novel targets in metastatic HNSCC
    Kondratyev, Maria
    Pesic, Aleksandra
    Ketela, Troy
    Sayad, Azin
    Marastoni, Stephano
    Mofat, Jason
    Virtanen, Carl
    Stickle, Natalie
    Grenman, Reider
    Wouters, Brad
    CANCER RESEARCH, 2018, 78 (13)